The dialysis method is classically used for drug separation before analysis, but, does not provide direct and real-time drug quantification and has limitations affecting the dialysis rate. In this study, a phosphorus nuclear magnetic resonance (31P-qNMR) method is developed for the real-time quantification of therapeutic molecules in vitro. The release kinetics of model drug tenofovir (TFV: anti-HIV microbicide) was analyzed in vaginal fluid simulant (VFS), semen fluid simulant (SFS), and human plasma (HP) from chitosan nanofibers (size ~100–200nm) using the NMR (direct) method and compared with dialysis/UV-Vis (indirect) method. The assay was linear in VFS/SFS (0.20–5.0mM), HP (0.30–5.0mM) and specific (no drug 31P-qNMR chemical shift (~15ppm) interference with formulation/media components). LOD values were 0.075/0.10/0.20mM, whereas, LOQ values were 0.20/0.20/0.30mM in VFS/SFS/HP, respectively. The method was robust, precise (%RSE <2%), and accurate (%mean recovery: 90-110%). After 12h, ~75%/72%/70%w/w of TFV release was observed with 31P-qNMR, compared to ~47%/52%/52%w/w by dialysis method in VFS/SFS/HP, respectively. Approximately 20% decrease in %drug release observed with dialysis method suggested an interference with drug transport process due to the dialysis membrane and the Gibbs-Donnan effect. Overall, 31P-qNMR provides more accurate, real-time and direct drug quantification for effective in vitro/in vivo correlation.